ANIX Anixa Biosciences, Inc.

$3.18

Anixa Biosciences, Inc. (ANIX) is expected to report earnings on September 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +32.5% since its last earnings release on June 10, 2026.

Anixa Biosciences Beat Consensus Estimates
Wednesday, June 10, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Jul 2026
Sep 9
Wednesday · After Close
Earnings Whisper
-
vs ($0.08)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.15

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.

Sector

Healthcare

Industry

Biotechnology